Debate continues over interferon-β for MS

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Debate continues over interferon-β for MS. Pharmacoecon. Outcomes News 102, 2 (1997). https://doi.org/10.1007/BF03271370

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.